Alkermes, based in Chelsea, MA, is a pharmaceutical company dedicated to leveraging their expertise in neuroscience to develop innovative medicines for complex psychiatric and neurological disorders. With a focus on research, development, and collaboration, Alkermes strives to make a real impact in the lives of patients and communities.
Driven by a culture of compassion and urgency, Alkermes employees work tirelessly in the laboratory, clinic, and community to advance treatments for difficult-to-treat diseases. Through their commitment to patient engagement, advocacy, and corporate responsibility, Alkermes is at the forefront of developing therapies that aim to address unmet medical needs.
Generated from the website
